AI video generators help you turn your prompts into believable videos, complete with audio. We've tested all the top services to help you choose the one that does the best job with the fewest tweaks.

The best AI art generators are DALL-E 3 for ease of use, Midjourney for photorealistic art, Craiyon for free access, Jasper Art for professional use, and NightCafe for experienced AI artists. AI art ...

Quick question: how did you learn to code? It probably wasn’t bribing someone a year or two ahead of you in CS to finish all your homework, but that’s exactly what ‘vibe coders’ are doing — even in ...

Quick question: how did you learn to code? It probably wasn’t bribing someone a year or two ahead of you in CS to finish all your homework, but that’s exactly what ‘vibe coders’ are doing — even in ...

STERLING, Va. — Not long after the enormous data center sprouted in Jessica Medeiros’s residential neighborhood, she began seeing black smoke. “There are times when the generators are running and … ...

AI has taken the world by storm over the last few years, with millions of users writing prompts on platforms like ChatGPT to generate content, images, and yes videos. Still, some of these platforms ...

Hundreds of thousands of generators sold at retailers such as Costco, Lowe’s and Home Depot are being recalled due to serious safety hazards. According to warnings from the U.S. Consumer Product ...

Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. Generate—which will list its stock on the Nasdaq this morning under ...

Feb 26 (Reuters) - Generate Biomedicines said on Thursday that it raised $400 million in its U.S. initial public offering, pricing shares of the U.S.-based drug developer at $16 each. The offering ...